Showing results (901-910 of 1,043) with videos related to
Sort By:
Pageof 105
Cancer|November 2, 2021
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse eventsEdward H Ip, Santiago Saldana, Kathy D Miller, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2013
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolizationRiad Salem, Margaret Gilbertsen, Zeeshan Butt, et al.Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsBryce B Reeve, Sandra A Mitchell, Amylou C Dueck, et al.Journal of Palliative Medicine|January 6, 2023
Death Anxiety in Huntington Disease: Longitudinal Heath-Related Quality-of-Life OutcomesLeonard L Sokol, Jonathan P Troost, Danny Bega, et al.Cancer|November 23, 2021
Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: Results from Fit2ThriveSiobhan M Phillips, Frank J Penedo, Linda M Collins, et al.European Urology Focus|September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation TherapyStéphane Oudard, Boris Hadaschik, Fred Saad, et al.Cancer|October 4, 2016
Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohortRoxanne E Jensen, Carol M Moinpour, Arnold L Potosky, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 14, 2007
IRT health outcomes data analysis project: an overview and summaryKaron F Cook, Cayla R Teal, Jakob B Bjorner, et al.Clinical Genitourinary Cancer|November 28, 2017
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) TrialYu-Ning Wong, Judith Manola, Gary R Hudes, et al.ESMO Open|August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trialsAndrew X Zhu, Ryan D Nipp, Richard S Finn, et al.Pageof 105